AINM.F Stock Overview
Develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
NetraMark Holdings Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.24 |
52 Week High | CA$0.32 |
52 Week Low | CA$0.14 |
Beta | 0.83 |
1 Month Change | 22.35% |
3 Month Change | n/a |
1 Year Change | -19.88% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -81.14% |
Recent News & Updates
Recent updates
Shareholder Returns
AINM.F | US Healthcare Services | US Market | |
---|---|---|---|
7D | 0% | 1.8% | 1.6% |
1Y | -19.9% | -2.5% | 26.1% |
Return vs Industry: AINM.F underperformed the US Healthcare Services industry which returned -3% over the past year.
Return vs Market: AINM.F underperformed the US Market which returned 26.8% over the past year.
Price Volatility
AINM.F volatility | |
---|---|
AINM.F Average Weekly Movement | n/a |
Healthcare Services Industry Average Movement | 10.7% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.3% |
10% least volatile stocks in US Market | 2.8% |
Stable Share Price: AINM.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine AINM.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2016 | n/a | George Achilleos | www.netramark.com |
NetraMark Holdings Inc. develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada. Its products suite comprises NetraAI, an interactive augmented intelligence platform; Netra Shatter; and Netra Health Atlas. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023.
NetraMark Holdings Inc. Fundamentals Summary
AINM.F fundamental statistics | |
---|---|
Market cap | US$13.32m |
Earnings (TTM) | -US$8.98m |
Revenue (TTM) | US$163.16k |
81.7x
P/S Ratio-1.5x
P/E RatioIs AINM.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AINM.F income statement (TTM) | |
---|---|
Revenue | CA$222.02k |
Cost of Revenue | CA$0 |
Gross Profit | CA$222.02k |
Other Expenses | CA$12.44m |
Earnings | -CA$12.22m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.18 |
Gross Margin | 100.00% |
Net Profit Margin | -5,504.18% |
Debt/Equity Ratio | 0% |
How did AINM.F perform over the long term?
See historical performance and comparison